Pancreatic Cancer – Epidemiology Insights (2016-2028)

Chapter 1. Research Background

1.1 Research Objectives

1.2 Definition

1.3 Research Scope

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By industry participant

2.2.1.2 By geography

2.2.2 Key Opinion Leaders (KOLs) Validation

2.3 Coverage of Epidemiology Analysis

2.4 Forecast Methodology

2.5 Assumptions for the Study

Chapter 3. Executive Summary

3.1 Voice of KOLs

Chapter 4. Introduction

4.1 Disease Overview

4.2 Causes and Risk Factors

4.3 Prognosis

4.4 Signs and Symptoms

4.5 Pathophysiology

4.6 Diagnosis

4.7 Treatment

4.8 Treatment Algorithm for Pancreatic Cancer

4.9 Unmet Medical Needs

4.9.1 Drug Efficacy

4.9.2 Early Diagnosis

4.9.3 Expanded Use of Currently Approved Therapy

4.9.4 Defined Treatment Algorithm

4.9.5 Improving Third-line Setting

Chapter 5. Pancreatic Cancer Epidemiology Forecast for 7MM

5.1 Epidemiology Forecast for 7MM

5.1.1 By Stage

5.1.2 By Sex

5.1.3 By Age Group

5.2 Epidemiology Forecast for the U.S.

5.2.1 By Stage

5.2.2 By Sex

5.2.3 By Age Group

5.3 Epidemiology Forecast for EU5

5.3.1 By Stage

5.3.2 By Sex

5.3.3 By Age Group

5.3.4 By Country

5.3.4.1 Germany

5.3.4.1.1 By stage

5.3.4.1.2 By sex

5.3.4.1.3 By age group

5.3.4.2 France

5.3.4.2.1 By stage

5.3.4.2.2 By sex

5.3.4.2.3 By age group

5.3.4.3 Italy

5.3.4.3.1 By stage

5.3.4.3.2 By sex

5.3.4.3.3 By age group

5.3.4.4 U.K.

5.3.4.4.1 By stage

5.3.4.4.2 By sex

5.3.4.4.3 By age group

5.3.4.5 Spain

5.3.4.5.1 By stage

5.3.4.5.2 By sex

5.3.4.5.3 By age group

5.4 Epidemiology Forecast for Japan

5.4.1 By Stage

5.4.2 By Sex

5.4.3 By Age Group

Chapter 6. Appendix

6.1 Abbreviations

6.2 Sources and References

6.3 Related Reports

 

LIST OF TABLES

 

TABLE 1 PANCREATIC CANCER EPIDEMIOLOGY IN 7MM (2016-2021)

TABLE 2 PANCREATIC CANCER EPIDEMIOLOGY IN 7MM (2022-2028)

TABLE 3 PANCREATIC CANCER INCIDENT CASES IN 7MM, BY STAGE (2016-2021)

TABLE 4 PANCREATIC CANCER INCIDENT CASES IN 7MM, BY STAGE (2022-2028)

TABLE 5 PANCREATIC CANCER INCIDENT CASES IN 7MM, BY SEX (2016-2021)

TABLE 6 PANCREATIC CANCER INCIDENT CASES IN 7MM, BY SEX (2022-2028)

TABLE 7 PANCREATIC CANCER INCIDENT CASES IN 7MM, BY AGE GROUP (2016-2021)

TABLE 8 PANCREATIC CANCER INCIDENT CASES IN 7MM, BY AGE GROUP (2022-2028)

TABLE 9 PANCREATIC CANCER EPIDEMIOLOGY IN THE U.S. (2016-2021)

TABLE 10 PANCREATIC CANCER EPIDEMIOLOGY IN THE U.S. (2022-2028)

TABLE 11 PANCREATIC CANCER INCIDENT CASES IN THE U.S., BY STAGE (2016-2021)

TABLE 12 PANCREATIC CANCER INCIDENT CASES IN THE U.S., BY STAGE (2022-2028)

TABLE 13 PANCREATIC CANCER INCIDENT CASES IN THE U.S., BY SEX (2016-2021)

TABLE 14 PANCREATIC CANCER INCIDENT CASES IN THE U.S., BY SEX (2022-2028)

TABLE 15 PANCREATIC CANCER INCIDENT CASES IN THE U.S., BY AGE GROUP (2016-2021)

TABLE 16 PANCREATIC CANCER INCIDENT CASES IN THE U.S., BY AGE GROUP (2022-2028)

TABLE 17 PANCREATIC CANCER EPIDEMIOLOGY IN EU5 (2016-2021)

TABLE 18 PANCREATIC CANCER EPIDEMIOLOGY IN EU5 (2022-2028)

TABLE 19 PANCREATIC CANCER INCIDENT CASES IN EU5, BY STAGE (2016-2021)

TABLE 20 PANCREATIC CANCER INCIDENT CASES IN EU5, BY STAGE (2022-2028)

TABLE 21 PANCREATIC CANCER INCIDENT CASES IN EU5, BY SEX (2016-2021)

TABLE 22 PANCREATIC CANCER INCIDENT CASES IN EU5, BY SEX (2022-2028)

TABLE 23 PANCREATIC CANCER INCIDENT CASES IN EU5, BY AGE GROUP (2016-2021)

TABLE 24 PANCREATIC CANCER INCIDENT CASES IN EU5, BY AGE GROUP (2022-2028)

TABLE 25 PANCREATIC CANCER EPIDEMIOLOGY IN GERMANY (2016-2021)

TABLE 26 PANCREATIC CANCER EPIDEMIOLOGY IN GERMANY (2022-2028)

TABLE 27 PANCREATIC CANCER INCIDENT CASES IN GERMANY, BY STAGE (2016-2021)

TABLE 28 PANCREATIC CANCER INCIDENT CASES IN GERMANY, BY STAGE (2022-2028)

TABLE 29 PANCREATIC CANCER INCIDENT CASES IN GERMANY, BY SEX (2016-2021)

TABLE 30 PANCREATIC CANCER INCIDENT CASES IN GERMANY, BY SEX (2022-2028)

TABLE 31 PANCREATIC CANCER INCIDENT CASES IN GERMANY, BY AGE GROUP (2016-2021)

TABLE 32 PANCREATIC CANCER INCIDENT CASES IN GERMANY, BY AGE GROUP (2022-2028)

TABLE 33 PANCREATIC CANCER EPIDEMIOLOGY IN FRANCE (2016-2021)

TABLE 34 PANCREATIC CANCER EPIDEMIOLOGY IN FRANCE (2022-2028)

TABLE 35 PANCREATIC CANCER INCIDENT CASES IN FRANCE, BY STAGE (2016-2021)

TABLE 36 PANCREATIC CANCER INCIDENT CASES IN FRANCE, BY STAGE (2022-2028)

TABLE 37 PANCREATIC CANCER INCIDENT CASES IN FRANCE, BY SEX (2016-2021)

TABLE 38 PANCREATIC CANCER INCIDENT CASES IN FRANCE, BY SEX (2022-2028)

TABLE 39 PANCREATIC CANCER INCIDENT CASES IN FRANCE, BY AGE GROUP (2016-2021)

TABLE 40 PANCREATIC CANCER INCIDENT CASES IN FRANCE, BY AGE GROUP (2022-2028)

TABLE 41 PANCREATIC CANCER EPIDEMIOLOGY IN ITALY (2016-2021)

TABLE 42 PANCREATIC CANCER EPIDEMIOLOGY IN ITALY (2022-2028)

TABLE 43 PANCREATIC CANCER INCIDENT CASES IN ITALY, BY STAGE (2016-2021)

TABLE 44 PANCREATIC CANCER INCIDENT CASES IN ITALY, BY STAGE (2022-2028)

TABLE 45 PANCREATIC CANCER INCIDENT CASES IN ITALY, BY SEX (2016-2021)

TABLE 46 PANCREATIC CANCER INCIDENT CASES IN ITALY, BY SEX (2022-2028)

TABLE 47 PANCREATIC CANCER INCIDENT CASES IN ITALY, BY AGE GROUP (2016-2021)

TABLE 48 PANCREATIC CANCER INCIDENT CASES IN ITALY, BY AGE GROUP (2022-2028)

TABLE 51 PANCREATIC CANCER INCIDENT CASES IN THE U.K., BY STAGE (2016-2021)

TABLE 52 PANCREATIC CANCER INCIDENT CASES IN THE U.K., BY STAGE (2022-2028)

TABLE 53 PANCREATIC CANCER INCIDENT CASES IN THE U.K., BY SEX (2016-2021)

TABLE 54 PANCREATIC CANCER INCIDENT CASES IN THE U.K., BY SEX (2022-2028)

TABLE 55 PANCREATIC CANCER INCIDENT CASES IN THE U.K., BY AGE GROUP (2016-2021)

TABLE 56 PANCREATIC CANCER INCIDENT CASES IN THE U.K., BY AGE GROUP (2022-2028)

TABLE 57 PANCREATIC CANCER EPIDEMIOLOGY IN SPAIN (2016-2021)

TABLE 58 PANCREATIC CANCER EPIDEMIOLOGY IN SPAIN (2022-2028)

TABLE 59 PANCREATIC CANCER INCIDENT CASES IN SPAIN, BY STAGE (2016-2021)

TABLE 60 PANCREATIC CANCER INCIDENT CASES IN SPAIN, BY STAGE (2022-2028)

TABLE 61 PANCREATIC CANCER INCIDENT CASES IN SPAIN, BY SEX (2016-2021)

TABLE 62 PANCREATIC CANCER INCIDENT CASES IN SPAIN, BY SEX (2022-2028)

TABLE 63 PANCREATIC CANCER INCIDENT CASES IN SPAIN, BY AGE GROUP (2016-2021)

TABLE 64 PANCREATIC CANCER INCIDENT CASES IN SPAIN, BY AGE GROUP (2022-2028)

TABLE 65 PANCREATIC CANCER EPIDEMIOLOGY IN JAPAN (2016-2021)

TABLE 66 PANCREATIC CANCER EPIDEMIOLOGY IN JAPAN (2022-2028)

TABLE 67 PANCREATIC CANCER INCIDENT CASES IN JAPAN, BY STAGE (2016-2021)

TABLE 68 PANCREATIC CANCER INCIDENT CASES IN JAPAN, BY STAGE (2022-2028)

TABLE 69 PANCREATIC CANCER INCIDENT CASES IN JAPAN, BY SEX (2016-2021)

TABLE 70 PANCREATIC CANCER INCIDENT CASES IN JAPAN, BY SEX (2022-2028)

TABLE 71 PANCREATIC CANCER INCIDENT CASES IN JAPAN, BY AGE GROUP (2016-2021)

TABLE 72 PANCREATIC CANCER INCIDENT CASES IN JAPAN, BY AGE GROUP (2022-2028)

TABLE 73 ABBREVIATIONS

TABLE 74 SOURCES AND REFERENCES

 

LIST OF FIGURES

 

FIG 1 RESEARCH METHODOLOGY

FIG 2 BREAKDOWN OF PRIMARY RESEARCH RESPONDENTS, BY INDUSTRY PARTICIPANT

FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY GEOGRAPHY

FIG 4 PANCREATIC CANCER EPIDIEMOLOGY SUMMARY

FIG 5 CORE SIGNALING PATHWAYS IN PANCREATIC CANCER

FIG 6 DIAGNOSTIC ALGORITHM FOR SUSPECTED PANCREATIC CANCER

FIG 7 TREATMENT ALGORITHM FOR PANCREATIC CANCER

FIG 8 PANCREATIC CANCER – UNMET NEEDS

FIG 9 TOTAL NUMBER OF INCIDENT CASES IN 7MM (2016 & 2028)

FIG 10 PANCREATIC CANCER INCIDENT CASES IN 7MM (2016-2028)

FIG 11 PANCREATIC CANCER INCIDENT CASES IN 7MM, BY STAGE (2016-2028)

FIG 12 PANCREATIC CANCER INCIDENT CASES IN 7MM, BY SEX (2016-2028)

FIG 13 PANCREATIC CANCER INCIDENT CASES IN 7MM, BY AGE GROUP (2016-2028)

FIG 14 PANCREATIC CANCER EPIDEMIOLOGY IN THE U.S. (2016-2028)

FIG 15 PANCREATIC CANCER INCIDENT CASES IN THE U.S., BY STAGE (2016-2028)

FIG 16 PANCREATIC CANCER INCIDENT CASES IN THE U.S., BY SEX (2016-2028)

FIG 17 PANCREATIC CANCER INCIDENT CASES IN THE U.S., BY AGE GROUP (2016-2028)

FIG 18 PANCREATIC CANCER EPIDEMIOLOGY IN EU5 (2016-2028)

FIG 19 PANCREATIC CANCER INCIDENT CASES IN EU5, BY STAGE (2016-2028)

FIG 20 PANCREATIC CANCER INCIDENT CASES IN EU5, BY SEX (2016-2028)

FIG 21 PANCREATIC CANCER INCIDENT CASES IN EU5, BY AGE GROUP (2016-2028)

FIG 22 PANCREATIC CANCER EPIDEMIOLOGY IN GERMANY (2016-2028)

FIG 23 PANCREATIC CANCER INCIDENT CASES IN GERMANY, BY STAGE (2016-2028)

FIG 24 PANCREATIC CANCER INCIDENT CASES IN GERMANY, BY SEX (2016-2028)

FIG 25 PANCREATIC CANCER INCIDENT CASES IN GERMANY, BY AGE GROUP (2016-2028)

FIG 26 PANCREATIC CANCER EPIDEMIOLOGY IN FRANCE (2016-2028)

FIG 27 PANCREATIC CANCER INCIDENT CASES IN FRANCE, BY STAGE (2016-2028)

FIG 28 PANCREATIC CANCER INCIDENT CASES IN FRANCE, BY SEX (2016-2028)

FIG 29 PANCREATIC CANCER INCIDENT CASES IN FRANCE, BY AGE GROUP (2016-2028)

FIG 30 PANCREATIC CANCER EPIDEMIOLOGY IN ITALY (2016-2028)

FIG 31 PANCREATIC CANCER INCIDENT CASES IN ITALY, BY STAGE (2016-2028)

FIG 32 PANCREATIC CANCER INCIDENT CASES IN ITALY, BY SEX (2016-2028)

FIG 33 PANCREATIC CANCER INCIDENT CASES IN ITALY, BY AGE GROUP (2016-2028)

FIG 34 PANCREATIC CANCER EPIDEMIOLOGY IN THE U.K. (2016-2028)

FIG 35 PANCREATIC CANCER INCIDENT CASES IN THE U.K., BY STAGE (2016-2028)

FIG 36 PANCREATIC CANCER INCIDENT CASES IN THE U.K., BY SEX (2016-2028)

FIG 37 PANCREATIC CANCER INCIDENT CASES IN THE U.K., BY AGE GROUP (2016-2028)

FIG 38 PANCREATIC CANCER EPIDEMIOLOGY IN SPAIN (2016-2028)

FIG 39 PANCREATIC CANCER INCIDENT CASES IN SPAIN, BY STAGE (2016-2028)

FIG 40 PANCREATIC CANCER INCIDENT CASES IN SPAIN, BY SEX (2016-2028)

FIG 41 PANCREATIC CANCER INCIDENT CASES IN SPAIN, BY AGE GROUP (2016-2028)

FIG 42 PANCREATIC CANCER EPIDEMIOLOGY IN JAPAN (2016-2028)

FIG 43 PANCREATIC CANCER INCIDENT CASES IN JAPAN, BY STAGE (2016-2028)

FIG 44 PANCREATIC CANCER INCIDENT CASES IN JAPAN, BY SEX (2016-2028)

FIG 45 PANCREATIC CANCER INCIDENT CASES IN JAPAN, BY AGE GROUP (2016-2028)